First Patient Treated With Ocriplasmin at Wills Eye Hospital
Allen C. Ho, MD, treated the first patient with ocriplasmin
(Jetrea; ThromboGenics) at the Wills Eye
Hospital in Philadelphia. Dr. Ho is a professor of ophthalmology
at Thomas Jefferson University Retina Service and Wills Eye Hospital and Chief Medical Editor of Advanced Ocular Care’s sister publication Retina Today.
...